277 results
Page 4 of 14
8-K
EX-99.2
o2yx4sos
25 Jul 13
Bristol-Myers Squibb Reports Second Quarter 2013 Financial Results
12:00am
8-K
EX-99.2
pfmuv7lu
25 Apr 13
Bristol-Myers Squibb Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99.2
1td7uenib8qu1fgn
24 Jan 13
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2012 Financial Results
12:00am
8-K
EX-99.2
onwwmvk1t3 jhru88
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
r0gsu0vpm a8xedyv
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
6a6fgyn1f3iis6jd9 ju
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-99.2
q3pywbkcb on29im
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-2.1
1io0fukfodgisf
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
CORRESP
jiq7 ib80mmtx
17 May 12
Correspondence with SEC
12:00am
8-K
EX-99.2
c30izvy9cl
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am
8-K
EX-99.1
pftl03wkcr6v9u oalf
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am